Need professional-grade analysis? Visit stockanalysis.com
$12.01B
30.03
65,000
1.06%
Price Chart
Risk-Adjusted Performance
Eurofins Scientific SE (ERF) Price Performance
Eurofins Scientific SE (ERF) trades on Euronext Paris in EUR. The company is classified in the Healthcare sector under the Diagnostics & Research industry. The stock currently trades at EUR61.08, down 2.27% from the previous close.
Over the past year, ERF has traded between a low of EUR45.49 and a high of EUR73.12. The stock has gained 22.5% over this period. It is currently 16.5% below its 52-week high.
Eurofins Scientific SE has a market capitalization of $12.01B, with a price-to-earnings ratio of 30.03 and a dividend yield of 1.06%.
About Eurofins Scientific SE
Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. It provides services, such as agroscience, including biological assessment, consumer and human, environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, including sustainability, audit, certification, quality inspection, QA-QC programme, and food and dietary supplement labelling services; biopharma, and clinical diagnostics. The company also offers consumer product testing, which include sustainability, testing, certifications and approvals, expert services and regulatory, inspections, audits, consumer research and sensory evaluation, and training courses; cosmetics and personal care; and electrical and electronics laboratories services. In addition, it provides environment testing, including maritime, water, air, soil, building material, pollution, waste, fuel/oil, microplastics, and radioactivity testing; and food and feed testing that include allergen, audit and certification, authenticity, carbohydrates, consulting, dioxins and POPs, food irradiation, GMO, heavy metal, melamine, microbiology, molecular biology, mycotoxin, nutritional analyses, organic contaminants, pesticide, veterinary drug, vitamin, and residual DNA testing. Further, the company provides forensic, genomic, maritime, materials and engineering, REACH, and sensory and consumer services, as well as in vitro diagnostics and PSS insourcing solutions. The company was founded in 1987 and is headquartered in Luxembourg, Luxembourg.
Company Info
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Exchange
- Euronext Paris
- Currency
- EUR
- Country
- France
Financial Metrics
- Revenue (TTM)
- $7.30B
- EBITDA
- $1.46B
- Profit Margin
- 6.51%
- EPS (TTM)
- 2.27
- Book Value
- 20.05
Technical Indicators
- 52 Week High
- €74.32
- 52 Week Low
- €45.05
- 50 Day MA
- €67.28
- 200 Day MA
- €62.97
- Beta
- 0.96
Valuation
- Trailing P/E
- 30.03
- Forward P/E
- 16.75
- Price/Sales
- 1.65
- Price/Book
- 2.59
- Enterprise Value
- $15.37B